Abiopharma

🔍 Fay Edmund (Executive)

Company: Encompass Health Corp (EHC)

Report Date: 2026-02-19

Detailed Transactions and Holdings:

• Sold 3,479 shares of Encompass Health Common Stock at $107.15 per share (Direct)
  Date: 2026-02-19 | Code: F | equity_swap_involved: 0 | shares_owned_after: 102,130.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 208 shares of Encompass Health Common Stock at $106.55 per share (Direct)
  Date: 2026-02-20 | Code: F | equity_swap_involved: 0 | shares_owned_after: 101,922.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.